COTA and Guardant Health Partner to Advance Precision Oncology with AI and Real-World Data

COTA Inc., a leader in real-world data (RWD) and analytics for oncology, has announced a new partnership with precision oncology company Guardant Health Inc. (Nasdaq: GH). This collaboration will provide biopharmaceutical researchers with access to COTA’s research-grade electronic health record…

Read MoreCOTA and Guardant Health Partner to Advance Precision Oncology with AI and Real-World Data
Blackstone

Palleon Pharmaceuticals and Henlius Collaborate on Glycan Editing for Autoimmune Diseases

Palleon Pharmaceuticals, a leader in glyco-immunology drug development for autoimmune diseases and cancer, has announced a collaboration and licensing agreement with Shanghai Henlius Biotech, Inc. (2696.HK). The agreement focuses on the development and commercialization of Palleon’s novel human sialidase enzyme…

Read MorePalleon Pharmaceuticals and Henlius Collaborate on Glycan Editing for Autoimmune Diseases

Insitro Secures $25 Million from Bristol Myers Squibb for ALS Target Discovery Milestones

Insitro, a machine learning-driven drug discovery and development company, announced today that it has received $25 million from Bristol Myers Squibb (NYSE: BMY) following the achievement of discovery milestones and the selection of the first novel genetic target for amyotrophic…

Read MoreInsitro Secures $25 Million from Bristol Myers Squibb for ALS Target Discovery Milestones

Valink Therapeutics Appoints Martin D. Williams as Board Chair, Names Scientific Advisory Board

Valink Therapeutics, a biopharmaceutical company focused on the discovery and development of bispecific antibody-drug conjugates (bsADCs) to treat cancer and other diseases, has announced the appointment of Martin D. Williams as Chair of its Board of Directors. Additionally, the company…

Read MoreValink Therapeutics Appoints Martin D. Williams as Board Chair, Names Scientific Advisory Board

ClearNote Health’s Avantect® Test Chosen for World’s Largest Pancreatic Cancer Detection Study

ClearNote Health, a company dedicated to enhancing early cancer detection, has announced a new partnership with researchers at the University of Southampton’s Clinical Trials Unit in the UK. The team will utilize ClearNote’s Avantect® Pancreatic Cancer Test in a groundbreaking…

Read MoreClearNote Health’s Avantect® Test Chosen for World’s Largest Pancreatic Cancer Detection Study

Noetik Unveils OCTO-VirtualCell and Celleporter: Key Models for Precision Oncology

Noetik, an AI-driven biotech company focused on developing next-generation cancer therapies using self-supervised machine learning and high-throughput spatial data, has announced the release of a technical report on OCTO-VirtualCell (OCTO-vc). This AI model is designed to predict the behavior of…

Read MoreNoetik Unveils OCTO-VirtualCell and Celleporter: Key Models for Precision Oncology

Western Washington Medical Group Partners with IKS Health to Boost Operations

IKS Health, a provider of care enablement platforms, has partnered with Western Washington Medical Group, a leading multi-specialty healthcare organization in Washington State. This collaboration is designed to help healthcare practices maintain autonomy and financial sustainability by streamlining revenue cycle…

Read MoreWestern Washington Medical Group Partners with IKS Health to Boost Operations

Knipper Health to Acquire Commercial Sample Management Business from Thermo Fisher

Knipper Health, Inc., the leading provider of end-to-end pharmaceutical healthcare marketing services in the U.S. for the biopharmaceutical and medical industries, has announced the acquisition of Patheon Pharma Services’ sample and fulfillment operations from Thermo Fisher Scientific, based in Memphis,…

Read MoreKnipper Health to Acquire Commercial Sample Management Business from Thermo Fisher